Colorado BioScience Association Names New Board Members

Leaders represent CereScan, Ocugen, Prevacept Infection Control, Sharklet and Zimmer Biomet

DENVER – April 23, 2018 – Colorado BioScience Association (CBSA) announces new members elected to its board of directors. The five new board members were introduced and approved during the organization’s annual board retreat on April 19.

Newly appointed board members

Jim Cloar, Zimmer Biomet, Vice President & Chief Commercial Officer, Spine & Robotics

Gino DiSciullo, Ph.D., Prevacept Infection Control, CEO

Charlie Kang, CFO, Ocugen

Ethan Mann, Ph.D., Sharklet, COO

Steve Warnecke, CereScan, Board Member & CFO; VetDC, Chairman & CFO; Evolutionary Genomics, Chairman & CEO

Jim Cloar

Gino DiSciullo, Ph.D.

Charlie Kang
Ethan Mann, Ph.D.
Steve Warnecke

Board members renewing their terms

Larry Blankenship, Evergreen Research, Director

Gary Connell, Sheridan Ross, Co-President, Shareholder

Brent Fassett, Cooley, Partner

Mark Lupa, Ph.D., High Country Venture, Partner

Fintan Steele, Ph.D., SomaLogic, Chief Communications and Culture Officer

Kiki Traylor, M.D., Amgen, Director of State Government Affairs

Steve VanNurden, Fitzsimons Innovation Campus, President & CEO

Dan Wittenberg, Snell & Wilmer, Partner

Shelly Zelin, AlloSource, Vice President of Human Resources

Scott Larson, Board Chairman of CBSA, says:

“It’s an honor to welcome Jim, Gino, Charlie, Ethan and Steve to the CBSA board. They represent leading Colorado digital health, biotech and medical device companies working to advance health care and improve lives. I look forward to drawing on their expertise as CBSA works to shape the future of our sector.”

April Giles, President and CEO of CBSA says:

“Colorado’s rapid growth brings new opportunities and talent to our state. CBSA leads policy and advocates for a business environment that supports all stages of innovation. We extend a warm welcome to our new board members and their perspectives. We also want to thank our outgoing board members for their commitment to Colorado BioScience Association, with a special thanks to our former board chairman Mark Spiecker his leadership and dedicated service to CBSA.”

CBSA board members commit to a three-year term and work in partnership with CBSA staff to support the growth of Colorado’s 720 life science companies.

Connect with CBSA: Twitter @COBioscience, Facebook and LinkedIn

About the Colorado BioScience AssociationColorado BioScience Association champions life science. We serve as the hub of Colorado’s thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. From promising young companies to established corporations and institutions, we provide opportunities for networking, education and professional development. We grow the bioscience workforce and lead business expansion policies to advance the industry in our state. CBSA represents more than 350 member organizations, including biotechnology, pharmaceutical, medical device, diagnostic, ag bio and mobile digital health companies, research and academic institutions and service providers. Learn more about us at

Media Contacts:

Sheliah Reynolds

Primavera Group for Colorado BioScience Association

(720) 289-4739

Categories: CBSA News